
“Needham suggests DraftKings Selloff as Long-term Investment Opportunity”
07/04/2025
Comments (0)
Despite March Madness outcomes impacting its short-term outlook, DraftKings maintains a Buy rating from Needham. The investing firm holds firm belief in DraftKings' long-term growth potential in the online sports betting and iGaming markets, despite recent market turbulence. The $65 price target communicates confidence in its resilience and future success. Read more
Read More
“Verizon Enhances Consumer Deals: Price Lock, Free Phones, UBS Neutral”
04/04/2025
Comments (0)
UBS maintains a neutral rating on Verizon (NYSE: VZ), despite the telecom giant unveiling new strategies to revitalize its postpaid wireless business. In an increasingly competitive market, Verizon's innovative customer initiatives aim to boost subscriber acquisition and retention, yet UBS believes potential growth and current valuation risks are yet balanced. Read more
Read More
“Johnson & Johnson Pressured After Talc Setback, Yet Growth Potential Intact”
04/04/2025
Comments (0)
Despite ongoing legal hurdles pertaining to its talc litigation, Johnson & Johnson maintains a positive outlook as UBS reaffirms its Buy rating and $180 price target. Factors such as performance of key drugs like Tremfya, strategic acquisitions, and continued innovation underpin UBS's confidence in the company's long-term growth potential. Read more
Read More